Company & Sponsor Intelligence
Cambridge University Hospitals NHS Foundation Trust
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting3
Completed0
Countries1
Therapeutic footprint
other_neurologyout_of_scopeparkinsons
Indexed studies
NCT07157735A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
parkinsons · United KingdomPHASE2
parkinsons · United KingdomPHASE2
NCT03240653Gaucherite - A Study to Stratify Gaucher Disease
other_neurology · United KingdomRECRUITING
other_neurology · United KingdomRECRUITING
NCT03900286Low Energy Diet and Familial Partial Lipodystrophy
out_of_scope · United KingdomNA
out_of_scope · United KingdomNA
Intelligence layer updated: 2026-10-12 03:39:50.393311+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →